Atlanta Precision Oncology Symposium - 2020

Gastrointestinal / Hematology / Melanoma

SATURDAY, FEBRUARY 8, 2020

Hotel at Avalon, Alpharetta, Georgia
9000 Avalon Blvd, Alpharetta, GA

REGISTER NOW

Symposium Overview

We invite you to join us for a one-day continuing education program that will focus on current approaches to integrating and applying precision medicine into
managing patients with melanoma, hematologic malignancies, and gastrointestinal cancers. Precision medicine, also known as personalized or individualized medicine, has been a long-standing dream for cancer patients and doctors. The last decade has brought amazing progress on this front. Thanks to the advent of precision medicine and the growing list of targeted therapies that have revolutionized the management of liquid and solid tumors, doctors can now rationally select treatments for cancer patients.

With progress in precision oncology comes complexity of patient care. Identification and validation of actionable targets and their variants, understanding post-target intracellular signaling pathway, selection of optimal targeted agent for first-line treatment, complexity of characterizing mechanisms of cancer cell resistance, and selection of alternative targeted agents to be used in second-line treatment and beyond, are just a few of the intricacies presented by precision medicine.

The Atlanta Precision Oncology Symposium (APOS) is designed to present the complexities of oncology precision medicine in an organized, simplified, friendly
fashion, so that they can be understood and properly applied to clinical medicine. Experts in the fields of melanoma, hematology, and gastrointestinal cancers will share the latest precision medicine advances and strategies for practical integration into the clinic.

The program will be of interest to those practicing in the context of academia, as well as those in the community oncology environment. Practitioners attending APOS will emerge from the program updated on recent data and armed with new tools to help them integrate precision medicine approaches into their daily clinical practice.

This meeting has been planned and will be implemented in accordance with the Essential Areas and Policies of the ACCME. CME, CNE, and pharmacy credit will also be offered.


Meet Our Speakers

Rodolfo E. Bordoni, MD

Rodolfo E. Bordoni, MD

Georgia Cancer Specialists | Atlanta, GA
Guillermo Garcia-Manero, MD

Guillermo Garcia-Manero, MD

MD Anderson Cancer Center | Houston, TX
Howard Hochster, MD

Howard Hochster, MD

Rutgers Cancer Institute of New Jersey | New Brunswick, NJ
Edward S. Kim, MD

Edward S. Kim, MD

Levine Cancer Center Institute | Charlotte, NC

David Lawson, MD

David Lawson, MD

Winship Cancer Institute of Emory University | Atlanta, GA
Rajarsi Mandal, MD

Rajarsi Mandal, MD

Johns Hopkins University School of Medicine | Baltimore, MD
Lawrence Morris, MD

Lawrence Morris, MD

Blood and Marrow Transplant Group of Georgia | Atlanta, GA
Anthony Olszanski, MD, RPh

Anthony Olszanski, MD, RPh

Fox Chase Cancer Center | Philadelphia, PA

Noopur Raje, MD

Noopur Raje, MD

Massachusetts General Hospital Cancer Center | Boston, MA
Kerry Rogers, MD

Kerry Rogers, MD

Ohio State University Comprehensive Cancer Center | Columbus, OH
Jeffrey A. Sosman, MD

Jeffrey A. Sosman, MD

Northwestern University Feinberg School of Medicine | Chicago, IL
Ahmad Tarhini, MD, PhD

Ahmad Tarhini, MD, PhD

Moffitt Comprehensive Cancer Center and Research Institute | Tampa, FL

Conference Schedule

Learning Objectives

  1. Describe the role of anti-BCMA CAR T-Cell therapy in relapsed or refractory multiple myeloma
  2. Identify new standard of care first-line regimens for patients with chronic lymphocytic leukemia
  3. Discuss novel treatment options for patients with very low-, low-, or intermediate-risk myelodysplastic syndrome who require RBC transfusions
  4. Navigate clinical trial results of new targeted treatment options for advanced BRAF V600–mutant melanoma patients
  5. Understand recent guidelines for molecular testing for stages III/IV melanoma
  6. Describe adjuvant and neoadjuvant treatment options for patients with high-risk melanoma
  7. Discuss how precision medicine can be incorporated into community-based oncology programs
  8. Understand the utility of the combined positive score for PDL-1 expression in considering immunotherapy for patients with gastric cancer
  9. Navigate the use of MMR status, MSI levels, and indel mutations in determining response to immunotherapy in gastrointestinal tumors
  10. Identify the use of serial liquid biopsies, exoDNA and ctDNA in determining the impact of treatment in patients with pancreatic cancer

CE Info

This meeting has been planned and will be implemented in accordance with the Essential Areas and Policies of the ACCME. CME, CNE, and pharmacy credit will also be offered.

Venue

Hotel at Avalon

(Conference Venue)
Hotel at Avalon, Alpharetta, Georgia
9000 Avalon Blvd, Alpharetta, GA
(678) 722-3600

Meet Our Sponsors

FOUNDING SPONSOR

Diamond Sponsors

DIAMOND

Gold Sponsors

GOLD

Silver Sponsors

SILVER

Bronze Sponsors

BRONZE

Become a Sponsor

Don't Miss Out!

Conference starts in: